Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Article CommentaryBrain

Daydreaming about Our Metaphorical Tool Belt

M.E. Mullins
American Journal of Neuroradiology March 2012, 33 (3) 569; DOI: https://doi.org/10.3174/ajnr.A2804
M.E. Mullins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

The article “The Effect of Age and Cerebral Ischemia on Diffusion-Weighted Proton MR Spectroscopy of the Human Brain”1 in this issue of AJNR showcases an MR imaging technique that is unusual (at least in my opinion) as compared with those that are commonly clinically employed: diffusion-weighted MR spectroscopy (DW-MRS).2⇓⇓–5 Arguably well-summarized in the abstract of a review by Nicolay and colleagues in NMR in Biomedicine in 2001, this research tool allows one to “noninvasively quantitate the translational displacement of endogenous metabolites in intact mammalian tissues.”4

We would seem to be in an era of increased emphasis on quantification, and this technique may eventually lend itself nicely to that paradigm. DW-MR imaging has been studied in nervous system and musculoskeletal tissues,4 and in normal and disease states, including ischemia and neoplasia.4 Some of the metabolites studied include glucose and lactate.3 In the current article,1 Zheng and colleagues apparently sought to establish any effects of aging on baseline measures and then to also evaluate ischemia effects, if any. Establishing “normal” or “expected” variations would seem to be a noble goal to help put quantitative measurements taken from patients with disease states into perspective. The prospect of being able to examine intra- and extracellular metabolites in a quantitative fashion in vivo seems quite enticing to me, and I hope that this technology continues to mature within the research milieu and eventually start to help us in the applied, clinical environment.

Ten years later, the concept of being able to examine intra- and extracellular metabolites likely remains one of great import. When discussing the clinical applications of the plethora of advanced neuroimaging techniques available today with trainees, I like to focus on the combination of physiology examined with the perceived short-list differential diagnosis based on conventional neuroimaging. For example, PWI seems to me to be essentially based on the flux of blood (of course, this is a great simplification but it seems like a good place to start such a discussion). In a patient with a high-grade primary brain tumor, after surgery, after chemotherapy, after radiation therapy, and with a new intracranial mass lesion, what is the predominant component and/or interval change related to? Predominant tumor progression? Predominant treatment effect? Something else? In my experience, predominant tumor progression and predominant treatment effect are usually at the top of the short-list differential diagnosis. I like to then apply the logical question of which of the advanced neuroimaging techniques would theoretically “split” the top differential diagnostic considerations the most, thus making them easier to separate as diagnostic imaging considerations. Theoretically, a high-grade primary brain tumor would have an elevated flux of blood into the region and necrosis would have a decreased (or absent) flux of blood. Of course, things change over time and the advent of antiangiogenesis medications introduced a remarkable variation into the process of choosing and applying PWI in similar settings. I have long been impressed with the ability of DWI to contribute to the characterization of intracranial mass lesions on conventional neuroimaging. In particular, in my experience, DWI seems quite adept at the implication of densely cellular tumor. The routine clinical use of DWI, I think, helped us to effectively transition interpretation of cases such as these. To be sure, the last few years have seen these processes become both refined and more complicated—we now have situations such as true progression, pseudoprogression, true response, pseudoresponse, and so on. Daydreaming about DW-MRS and this article, I wonder if this could be another tool (in our metaphorical neuroimaging tool belt) for us in the ever-challenging, ever-changing arena of brain tumor imaging? Could this technique give us further insight into intracellular and extracellular metabolite diffusion and, if so, can that translate well to the applied clinical arena? Will we someday be deciding about whether or not to suggest a PET or a DW-MRS when confronted with a particularly challenging case? Or could DW-MRS become as commonplace as PWI or even DWI? Only time will tell. In the meantime, I can dream.

To finish this commentary, let us revisit the review article by Nicolay and colleagues for a closing summary thought: “In vivo diffusion-weighted MR spectroscopy…offers unprecedented opportunities for assessing the biophysical chemistry of intracellular metabolites, from which (ultra)structural details of the intracellular compartment can be noninvasively inferred.”4

References

  1. 1.↵
    1. Zheng DD,
    2. Liu ZH,
    3. Fang F,
    4. et al
    . The effect of age and cerebral ischemia on diffusion-weighted proton MR spectroscopy of the human brain. AJNR Am J Neuroradiol 2012; (in press)
  2. 2.↵
    1. Nicolay K,
    2. van der Toorn A,
    3. Dijkhuizen RM
    . In vivo diffusion spectroscopy. An overview. NMR Biomed 1995; 8: 365–74
    PubMed
  3. 3.↵
    1. Pfeuffer J,
    2. Tkac I,
    3. Gruetter R
    . Extracellular-intracellular distribution of glucose and lactate in the rat brain assessed noninvasively by diffusion-weighted 1H nuclear magnetic resonance spectroscopy in vivo. J Cereb Blood Flow Metab 2000;20: 736–46
    PubMed
  4. 4.↵
    1. Nicolay K,
    2. Braun KP,
    3. Graaf RA,
    4. et al
    . Diffusion NMR spectroscopy. NMR Biomed 2001; 14: 94–111
    CrossRefPubMed
  5. 5.↵
    1. Harada M,
    2. Uno M,
    3. Hong F,
    4. et al
    . Diffusion-weighted in vivo localized proton MR spectroscopy of human cerebral ischemia and tumor. NMR Biomed 2002; 15: 69–74
    CrossRefPubMed
  • © 2012 by American Journal of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 33 (3)
American Journal of Neuroradiology
Vol. 33, Issue 3
1 Mar 2012
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Daydreaming about Our Metaphorical Tool Belt
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Daydreaming about Our Metaphorical Tool Belt
M.E. Mullins
American Journal of Neuroradiology Mar 2012, 33 (3) 569; DOI: 10.3174/ajnr.A2804

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Daydreaming about Our Metaphorical Tool Belt
M.E. Mullins
American Journal of Neuroradiology Mar 2012, 33 (3) 569; DOI: 10.3174/ajnr.A2804
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease
  • White Matter Alterations in the Brains of Patients with Active, Remitted, and Cured Cushing Syndrome: A DTI Study
  • Qualitative and Quantitative Analysis of MR Imaging Findings in Patients with Middle Cerebral Artery Stroke Implanted with Mesenchymal Stem Cells
Show more BRAIN

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire